Wealth Enhancement Advisory Services LLC Acquires 4,721 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Wealth Enhancement Advisory Services LLC boosted its holdings in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 153.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,800 shares of the company's stock after purchasing an additional 4,721 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Inspire Medical Systems were worth $1,646,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of INSP. Russell Investments Group Ltd. increased its stake in shares of Inspire Medical Systems by 98.9% during the 1st quarter. Russell Investments Group Ltd. now owns 31,933 shares of the company's stock worth $6,859,000 after purchasing an additional 15,877 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Inspire Medical Systems by 51.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 459,766 shares of the company's stock worth $98,754,000 after buying an additional 156,893 shares during the last quarter. Tidal Investments LLC bought a new stake in shares of Inspire Medical Systems in the first quarter valued at $1,151,000. AQR Capital Management LLC lifted its position in shares of Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company's stock valued at $31,028,000 after buying an additional 140,090 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky grew its stake in shares of Inspire Medical Systems by 27.1% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 40,501 shares of the company's stock worth $8,699,000 after acquiring an additional 8,625 shares during the period. Hedge funds and other institutional investors own 94.91% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on INSP. KeyCorp lowered their price objective on Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 7th. Truist Financial restated a "buy" rating and set a $240.00 price target (up from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Robert W. Baird reduced their price objective on shares of Inspire Medical Systems from $220.00 to $200.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. Royal Bank of Canada restated an "outperform" rating and set a $260.00 target price on shares of Inspire Medical Systems in a research report on Wednesday, August 7th. Finally, Morgan Stanley reduced their price target on Inspire Medical Systems from $250.00 to $210.00 and set an "overweight" rating for the company in a research report on Monday, July 15th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $219.58.

Insider Activity at Inspire Medical Systems

In other news, Director Shawn Mccormick sold 800 shares of the company's stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the transaction, the director now directly owns 23,140 shares in the company, valued at approximately $5,090,800. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Randy Ban sold 4,861 shares of the business's stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total value of $916,541.55. Following the completion of the sale, the insider now owns 3,056 shares of the company's stock, valued at approximately $576,208.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Shawn Mccormick sold 800 shares of the firm's stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the transaction, the director now owns 23,140 shares in the company, valued at approximately $5,090,800. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,692 shares of company stock valued at $1,099,207 over the last 90 days. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Price Performance

NYSE INSP traded up $2.00 during trading on Monday, reaching $192.71. The company's stock had a trading volume of 789,989 shares, compared to its average volume of 595,077. The firm has a fifty day moving average of $201.15 and a 200 day moving average of $179.93. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The stock has a market capitalization of $5.75 billion, a PE ratio of 1,070.61 and a beta of 1.36.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.46. Inspire Medical Systems had a net margin of 0.85% and a return on equity of 1.03%. The company had revenue of $195.89 million for the quarter, compared to analysts' expectations of $189.08 million. During the same period in the prior year, the business earned ($0.41) earnings per share. Inspire Medical Systems's revenue for the quarter was up 29.6% compared to the same quarter last year. Research analysts expect that Inspire Medical Systems, Inc. will post 0.75 earnings per share for the current fiscal year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.